# Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy

> **NCT00905853** · PHASE4 · COMPLETED · sponsor: **John Sapp** · enrollment: 260 (actual)

## Conditions studied

- Recurrent Ventricular Tachycardia

## Interventions

- **PROCEDURE:** Catheter Ablation
- **DRUG:** Escalated Antiarrhythmic Therapy

## Key facts

- **NCT ID:** NCT00905853
- **Lead sponsor:** John Sapp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2016-07-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905853, "Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00905853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*